Cite
HARVARD Citation
Dosne, A. et al. (2023). Population pharmacokinetics and exposure–response analyses of daratumumab plus pomalidomide/dexamethasone in relapsed or refractory multiple myeloma. British journal of clinical pharmacology. 89 (5), pp. 1640-1655. [Online].